Clinical and genetic determinants of chronic visual pathway changes after methanol - induced optic neuropathy: four-year follow-up study

References

• Paasma R, Hovda KE, Tikkerberi A, et al. Methanol mass poisoning in Estonia: outbreak in 154 patients. Clin Toxicol. 2007;45:152–157.
   PubMed Web of Science ®Google Scholar
• Hovda KE, Hunderi OH, Tafjord AB, et al. Methanol outbreak in Norway 2002–2004: epidemiology, clinical features and prognostic signs. J Intern Med. 2005;258:181–190.
   PubMed Web of Science ®Google Scholar
• Rostrup M, Edwards JK, Abukalish M, et al. The methanol poisoning outbreaks in Libya 2013 and Kenya 2014. PLoS One. 2016;11:e0152676.
   PubMed Web of Science ®Google Scholar
• Bezdicek O, Michalec J, Vaneckova M, et al. Cognitive sequelae of methanol poisoning involve executive dysfunction and memory impairment in cross-sectional and long-term perspective. Alcohol. 2017;59:27–35.
   PubMed Web of Science ®Google Scholar
• Peterova K, Brozova H, Klempir J, et al. Gait and balance impairment after acute methanol poisoning. Basic Clin Pharmacol Toxicol. 2018;122:176–182.
   PubMed Web of Science ®Google Scholar
• McMartin K, Jacobsen D, Hovda KE. Antidotes for poisoning by alcohols that form toxic metabolites. Br J Clin Pharmacol. 2016;81:505–515.
   PubMed Web of Science ®Google Scholar
• Zakharov S, Pelclova D, Navratil T, et al. Fomepizole versus ethanol in the treatment of acute methanol poisoning: comparison of clinical effectiveness in a mass poisoning outbreak. Clin Toxicol. 2015;53:797–806.
   PubMed Web of Science ®Google Scholar
• Zakharov S, Pelclova D, Urban P, et al. Use of out-of-hospital ethanol administration to improve outcome in mass methanol outbreaks. Ann Emerg Med. 2016;68:52–61.
   PubMed Web of Science ®Google Scholar
• Zakharov S, Nurieva O, Kotikova K, et al. Positive serum ethanol concentration on admission to hospital as the factor predictive of treatment outcome in acute methanol poisoning. Monatsh Chem. 2017;148:409–419.
   PubMed Web of Science ®Google Scholar
• Liesivuori J, Savolainen H. Methanol and formic acid toxicity: biochemical mechanisms. Pharmacol Toxicol. 1991;69:157–163.
   PubMedGoogle Scholar
• Eells JT, Henry MM, Lewandowski MF, et al. Development and characterization of a rodent model of methanol-induced retinal and optic nerve toxicity. Neurotoxicology. 2000;21:321–330.
   PubMed Web of Science ®Google Scholar
• Zakharov S, Kurcova I, Navratil T, et al. Is the measurement of serum formate concentration useful in the diagnostics of acute methanol poisoning? A prospective study of 38 patients. Basic Clin Pharmacol Toxicol. 2015;116:445–451.
   PubMed Web of Science ®Google Scholar
• Hlusicka J, Loster T, Lischkova L, et al. Role of activation of lipid peroxidation in the mechanisms of acute methanol poisoning. Clin Toxicol (Phila). 2018;56(10):893–903.
   PubMed Web of Science ®Google Scholar
• Yu DY, Cringle SJ. Oxygen distribution and consumption within the retina in vascularized and avascular retinas and in animal models of retinal disease. Prog Retin Eye Res. 2001;20:175–208.
   PubMed Web of Science ®Google Scholar
• Carelli V, Ross-Cisneros FN, Sadun AA. Mitochondrial dysfunction as a cause of optic neuropathies. Prog Retin Eye Res. 2004;23:53–89.
   PubMed Web of Science ®Google Scholar
• Seme MT, Summerfelt P, Neitz J, et al. Differential recovery of retinal function after mitochondrial inhibition by methanol intoxication. Invest Ophthalmol Vis Sci. 2001;42:834–841.
   PubMed Web of Science ®Google Scholar
• Sanaei-Zadeh H, Zamani N, Shadnia S. Outcomes of visual disturbances after methanol poisoning. Clin Toxicol. 2011;49:102–107.
   PubMed Web of Science ®Google Scholar
• Zakharov S, Pelclova D, Diblik P, et al. Long-term visual damage after acute methanol poisonings: longitudinal cross-sectional study in 50 patients. Clin Toxicol. 2015;53:884–892.
   PubMed Web of Science ®Google Scholar
• Desai T, Sudhalkar A, Vyas U, et al. Methanol poisoning: predictors of visual outcomes. JAMA Ophthalmol. 2013;131:358–364.
   PubMed Web of Science ®Google Scholar
• Paasma R, Hovda KE, Jacobsen D. Methanol poisoning and long term sequelae - a six years follow-up after a large methanol outbreak. BMC Clin Pharmacol. 2009;9:5.
   PubMedGoogle Scholar
• Brusa A, Jones SJ, Kapoor R, et al. Long-term recovery and fellow eye deterioration after optic neuritis, determined by serial visual evoked potentials. J Neurol. 1999;246:776–782.
   PubMed Web of Science ®Google Scholar
• Brusa A, Jones SJ, Plant GT. Long-term remyelination after optic neuritis: a 2-year visual evoked potential and psychophysical serial study. Brain. 2001;124:468–479.
   PubMed Web of Science ®Google Scholar
• Jones SJ, Brusa A. Neurophysiological evidence for long-term repair of MS lesions: implications for axon protection. J Neurol Sci. 2003;206:193–198.
   PubMed Web of Science ®Google Scholar
• Zakharov S, Pelclova D, Urban P, et al. Czech mass methanol outbreak 2012: epidemiology, challenges and clinical features. Clin Toxicol. 2014;52:1013–1024.
   PubMed Web of Science ®Google Scholar
• Barceloux DG, Bond GR, Krenzelok EP, et al. American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning. J Toxicol Clin Toxicol. 2002;40:415–446.
   PubMed Web of Science ®Google Scholar
• Zakharov S, Navratil T, Pelclova D. Fomepizole in the treatment of acute methanol poisonings: experience from the Czech mass methanol outbreak 2012–2013. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014;158:641–649.
   PubMed Web of Science ®Google Scholar
• Zakharov S, Navratil T, Salek T, et al. Fluctuations in serum ethanol concentration in the treatment of acute methanol poisoning: a prospective study of 21 patients. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015;159:666–676.
   PubMed Web of Science ®Google Scholar
• Zakharov S, Pelclova D, Navratil T, et al. Efficiency of acidemia correction on intermittent versus continuous hemodialysis in acute methanol poisoning. Clin Toxicol. 2017;55:123–132.
   PubMed Web of Science ®Google Scholar
• Zakharov S, Rulisek J, Nurieva O, et al. Intermittent versus continuous renal replacement therapy in acute methanol poisoning: comparison of clinical effectiveness in mass poisoning outbreaks. Ann Intensive Care. 2017;7:77.
   PubMed Web of Science ®Google Scholar
• Zakharov S, Nurieva O, Navratil T, et al. Acute methanol poisonings: folates administration and visual sequelae. J Appl Biomed. 2014;12:309–316.
   Web of Science ®Google Scholar
• Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.
   PubMed Web of Science ®Google Scholar
• Hubacek JA, Piper BJ, Pikhart H, et al. Lack of an association between left-handedness and APOE polymorphism in a large sample of adults: results of the Czech HAPIEE study. Laterality. 2013;18:513–519.
   PubMed Web of Science ®Google Scholar
• Zakharov S, Kotikova K, Nurieva O, et al. Leukotriene-mediated neuroinflammation, toxic brain damage, and neurodegeneration in acute methanol poisoning. Clin Toxicol. 2017;55:249–259.
   PubMed Web of Science ®Google Scholar
• Zakharov S, Kotikova K, Vaneckova M, et al. Acute methanol poisoning: prevalence and predisposing factors of haemorrhagic and non-haemorrhagic brain lesions. Basic Clin Pharmacol Toxicol. 2016;119:228–238.
   PubMed Web of Science ®Google Scholar
• Nurieva O, Diblik P, Kuthan P, et al. Progressive chronic retinal axonal loss following acute methanol-induced optic neuropathy: four-year prospective cohort study. Am J Ophthalmol. 2018;191:100–115.
   PubMed Web of Science ®Google Scholar
• Vaneckova M, Zakharov S, Klempir J, et al. Imaging findings after methanol intoxication (cohort of 46 patients). Neuro Endocrinol Letters. 2015;36:737–744.
   PubMed Web of Science ®Google Scholar
• Bezdicek O, Klempir J, Liskova I, et al. Sequelae of methanol poisoning for cognition. Cesk Slov Neurol N. 2014;77/110:320–325.
   Google Scholar
• Zakharov S, Hlusicka J, Nurieva O, et al. Neuroinflammation markers and methyl alcohol induced toxic brain damage. Toxicol Lett. 2018;pii:S0378–4274(18)30175–9.
   PubMed Web of Science ®Google Scholar
• Vaneckova M, Zakharov S, Klempir J, et al. Methanol intoxication on magnetic resonance imaging – case reports. Cesk Slov Neurol Neurochir. 2014;77:235–239.
   Google Scholar
• Rulisek J, Balik M, Polak F, et al. Cost-effectiveness of hospital treatment and outcomes of acute methanol poisoning during the Czech Republic mass poisoning outbreak. J Crit Care. 2017;39:190–198.
   PubMed Web of Science ®Google Scholar
• Zakharov S, Nurieva O, Kotikova K, et al. Factors predicting optic nerve axonal degeneration after methanol-induced acute optic neuropathy: a two-year prospective study in 54 patients. Monatsh Chem. 2016;147:251–261.
   Web of Science ®Google Scholar
• Zhao XJ, Lu L, Li M, et al. Ophthalmic findings in two cases of methanol optic neuropathy with relapsed vision disturbance. Int J Ophthalmol. 2015;8:427–429.
   PubMed Web of Science ®Google Scholar
• Nurieva O, Kotikova K, Urban P, et al. Prevalence, dynamics, and biochemical predictors of optic nerve remyelination after methanol-induced acute optic neuropathy: a two-year prospective study in 54 patients. Monatsh Chem. 2016;147:239–249.
   Web of Science ®Google Scholar
• Urban P, Zakharov S, Diblík P, et al. Visual evoked potentials in patients after methanol poisoning. Int J Occup Med Environ Health. 2015;29:471–478.
   Web of Science ®Google Scholar
• Paasma R, Hovda KE, Hassanian-Moghaddam H, et al. Risk factors related to poor outcome after methanol poisoning and the relation between outcome and antidotes - a multicenter study. Clin Toxicol. 2012;50:823–831.
   PubMed Web of Science ®Google Scholar
• Zakharov S, Navratil T, Pelclova D. Analysis of serum anion gap and osmolal gap in diagnosis and prognosis of acute methanol poisoning: clinical study in 86 patients. Monatsh Chem. 2015;146:787–794.
   Web of Science ®Google Scholar
• Drangsholt E, Vangstad M, Zakharov S, et al. The hypothesis of circulus hypoxicus and its clinical relevance in patients with methanol poisoning - an observational study of 35 patients. Basic Clin Pharmacol Toxicol. 2018. doi:10.1111/bcpt.13074
   PubMed Web of Science ®Google Scholar
• Zakharov S, Pelclova D, Navratil T, et al. Intermittent hemodialysis is superior to continuous veno-venous hemodialysis/hemodiafiltration to eliminate methanol and formate during treatment for methanol poisoning. Kidney Int. 2014;86:199–207.
   PubMed Web of Science ®Google Scholar
• Misra UK, Kalita J, Das A. Vitamin B12 deficiency neurological syndromes: a clinical MRI and electrodiagnostic study. Electromyogr Clin Neurophysiol. 2003;43:57–64.
   PubMedGoogle Scholar
• Fei G-q, Zhong C, Jin L, et al. Clinical characteristics and MR imaging features of nonalcoholic Wernicke encephalopathy. AJNR Am J Neuroradiol. 2008;29:164–169.
   PubMed Web of Science ®Google Scholar
• Yeh W-Y, Lian L-M, Chang A, et al. Thiamine-deficient optic neuropathy associated with Wernicke’s encephalopathy in patients with chronic diarrhea. J Formos Med Assoc. 2013;112:165–170.
   PubMed Web of Science ®Google Scholar
• Fernandez M, Giuliani A, Pirondi S, et al. Thyroid hormone administration enhances remyelination in chronic demyelinating inflammatory disease. Proc Natl Acad Sci USA. 2004;101:16363–16368. 16
   PubMed Web of Science ®Google Scholar
• Veselinovic D, Jovanovic M. Diabetes mellitus and optic nerve diseases. Acta Fac Med NAISS. 2005;22:145–148.
   Google Scholar
• Hubacek JA, Jirsa M, Bobak M, et al. Aldehyde dehydrogenase 2 polymorphism affects the outcome of methanol poisoning in exposed humans. Clin Genet. 2018;94(5):445–449.
   PubMed Web of Science ®Google Scholar
• Hubacek JA, Pelclova D, Seidl Z, et al. Rare alleles within the CYP2E1 (MEOS system) could be associated with better short-term health outcome after acute methanol poisoning. Basic Clin Pharmacol Toxicol. 2015;116:168–172.
   PubMed Web of Science ®Google Scholar
• Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci. 1994;17:525–530.
   PubMed Web of Science ®Google Scholar
• Amaratunga A, Abraham CR, Edwards RB, et al. Apolipoprotein E is synthesized in the retina by Müller glial cells, secreted into the vitreous, and rapidly transported into the optic nerve by retinal ganglion cells. J Biol Chem. 1996;271:5628–5632.
   PubMed Web of Science ®Google Scholar
• Nathan BP, Bellosta S, Sanan DA, et al. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science. 1994;264:850–852.
   PubMed Web of Science ®Google Scholar
• Fullerton SM, Shirman GA, Strittmatter WJ, et al. Impairment of the blood-nerve and blood-brain barriers in apolipoprotein E knockout mice. Exp Neurol. 2001;169:13–22.
   PubMed Web of Science ®Google Scholar
• Wong TY, Mitchell P. Hypertensive retinopathy. N Engl J Med. 2004;351:2310–2317.
   PubMed Web of Science ®Google Scholar
• Chen HK, Ji ZS, Dodson SE, et al. Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease. J Biol Chem. 2011;286:5215–5221.
   PubMed Web of Science ®Google Scholar
• Bellosta S, Nathan BP, Orth M, et al. Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth. J Biol Chem. 1995;270:27063–27071.
   PubMed Web of Science ®Google Scholar
• Brodbeck J, Balestra ME, Saunders AM, et al. Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons. Proc Natl Acad Sci USA. 2008;105:1343–1346.
   PubMed Web of Science ®Google Scholar
• Chen HK, Liu Z, Meyer-Franke A, et al. Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons. J Biol Chem. 2012;287:5253–5266.
   PubMed Web of Science ®Google Scholar
• Maharshak I, Salomon-Zimri S, Antes R, et al. The effects of the apoE4 genotype on the developing mouse retina. Exp Eye Res. 2016;145:17–25.
   PubMed Web of Science ®Google Scholar
• Antes R, Ezra-Elia R, Weinberger D, et al. ApoE4 induces synaptic and ERG impairments in the retina of young targeted replacement apoE4 mice. PLoS One. 2013;8:e64949.
   PubMed Web of Science ®Google Scholar